Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
CLNE
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Forecast
2026-Revenue
2026-EPS
2026-EBITDA
Analyst rating
Price Target
0.00(N/A)
Number of analyst
0
Last analyst upgrade/downgrade
Jefferies
downgradePrevious: Not converted
2025-08-08
Now: Hold
Raymond James
upgradePrevious: Outperform
2023-10-03
Now: Strong Buy
Raymond James
upgradePrevious: Market Perform
2022-08-16
Now: Outperform
Raymond James
upgradePrevious: Not converted
2022-05-10
Now: Market Perform
Quote Panel
Key Metrics
seekingalpha.com
9 hours ago
youtube.com
9 hours ago
fool.com
13 hours ago
fool.com
18 hours ago
zacks.com
19 hours ago
seekingalpha.com
21 hours ago
Earnings Growth
YoY
Current
Estimates
Q3.23
N/A
-0.12
vs 0.06
Q4.23
N/A
0.01
vs 0.01
Q1.24
N/A
-0.01
vs -0.07
Q2.24
+114%
0.01
vs -0.07
Q3.24
+117%
0.02
vs -0.12
Q4.24
+100%
0.02
vs 0.01
Q1.25
+200%
0.01
vs -0.01
Q2.25
N/A
-0.01
vs 0.01
Q3.25
N/A
-0.07
vs 0.02
Q4.25
N/A
-0.07
vs 0.02
Sales Growth
YoY
Current
Estimates
Q3.23
-24%
95.6M vs 125.7M
Q4.23
-6%
106.7M vs 113.8M
Q1.24
-23%
102.1M vs 132.2M
Q2.24
+8%
97.9M vs 90.5M
Q3.24
+10%
104.9M vs 95.6M
Q4.24
+2%
109.3M vs 106.7M
Q1.25
+2%
103.8M vs 102.1M
Q2.25
+5%
102.6M vs 97.9M
Q3.25
0%
104.9M vs 104.9M
Q4.25
-1%
107.8M vs 109.3M
Return on Equity
QoQ
Q1.23
-6%
-0.06
vs -0.02
Q2.23
-2%
-0.02
vs -0.06
Q3.23
-4%
-0.04
vs -0.02
Q4.23
-3%
-0.03
vs -0.04
Q1.24
-3%
-0.03
vs -0.03
Q2.24
-2%
-0.02
vs -0.03
Q3.24
-3%
-0.03
vs -0.02
Q4.24
-4%
-0.04
vs -0.03
Q1.25
-23%
-0.23
vs -0.04
Q2.25
-3%
-0.03
vs -0.23
Institutionnal Ownership
QoQ
Q4.22
242
242
vs 228
6%
Q1.23
227
227
vs 242
-6%
Q2.23
212
212
vs 227
-7%
Q3.23
225
225
vs 212
6%
Q4.23
230
230
vs 225
2%
Q1.24
224
224
vs 230
-3%
Q2.24
214
214
vs 224
-4%
Q3.24
218
218
vs 214
2%
Q4.24
229
229
vs 218
5%
Q1.25
216
216
vs 229
-6%
Relative Strength
CLNE
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|